Think Bioscience bolsters drug development expertise and deepens relationship with Colorado life science ecosystem following a $17M financing. BOULDER, Colo., Sept. 6, 2022 /PRNewswire/ — Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on developing…
Related Articles
News
Stanford Medicine and GHX Named a Finalist in 2022 Constellation Research SuperNova Awards
August 18, 2022
UCBN
News
Comments Off on Stanford Medicine and GHX Named a Finalist in 2022 Constellation Research SuperNova Awards
Recognized in Data to Decisions Category for Disruptive Technology Leadership LOUISVILLE, Colo., Aug. 18, 2022 /PRNewswire/ — GHX today announced customer Stanford Medicine has been named a finalist in the 12th annual Constellation Research “SuperNova […]
News
CSL Plasma Reimagines Donor Experience With First Donations Completed on Innovative Plasma Collection Technology
August 4, 2022
UCBN
News
Comments Off on CSL Plasma Reimagines Donor Experience With First Donations Completed on Innovative Plasma Collection Technology
New technology is designed to reduce collection time and improve donor experience; Aurora, Colorado, location is first of 300-plus CSL Plasma U.S. centers to convert to Rika Plasma Donation System BOCA RATON, Fla., Aug. 4, […]
News
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
May 21, 2024
UCBN
News, Syndication
Comments Off on Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
LOUISVILLE, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced that new data will be presented today at the 2024 American Thoracic Society (ATS) International […]
